嗅覺神經修復之生物治療新策略。2026年，Docquity Taiwan（醫群萬邦）攜手 Aplus Biotechnology（愛派司生技），共同推出系列線上研討會「生生不息 Biologics in Surgeries」。

本系列以再生醫療為核心主軸，透過亞洲最大醫師專用平台
Docquity，邀請各專科領域專家，分享 PRP在臨床中的實務應用與治療經驗，讓知識不只停留於單一場域，而能持續被擴散與深化。

從Ep1 到Ep5，我們聚焦耳鼻喉科領域，主題涵蓋鼻部重建、甲狀腺手術到聲帶治療，逐步建立系統性的內容脈絡，為醫師用戶帶來更貼近臨床決策的專業洞見。這不只是單場活動的累積，而是長期內容價值的持續堆疊。

不同於過往以線上為主的形式，本次Ep5（4月29日）有幸於台中榮民總醫院 舉辦hybrid 混合式研討會，除了線上直播外，也開放醫師現場參與，讓學習不只是單向接收，更能透過即時互動，深化交流的溫度與密度。

很感謝愛派司的信任，讓我們能從前期規劃、平台上架、行銷推廣，到實體會議執行，提供一條龍的整合服務，也讓平台的連結力與執行力在每個細節中被實踐。同時，也謝謝現場20多位醫師與線上近200位醫師的投入參與，讓這場交流更具意義。

在醫療快速演進的時代，如何讓專業被更有效地連結、被更廣泛地看見，始終是我們在思考的核心。未來，也期待持續透過平台與內容，推動更多有價值的知識交流，讓影響力不只停留於當下，而能持續發酵。

In 2026, Docquity Taiwan partnered with Aplus Biotechnology to launch the “Biologics in Surgeries"webinar series.

Centered on regenerative medicine, the series brought together cross-specialty experts via Docquity-Asia’s largest platform for verified physicians—to share real-world applications of PRP. Beyond individual sessions, the focus was on enabling knowledge to continuously circulate and create lasting impact.

From Episode 1 to 5, we focused on otolaryngology, covering topics from nasal reconstruction and thyroid surgery to vocal cord treatments. Each session built on the last, forming a structured and clinically relevant knowledge journey.

Episode 5 (April 29) marked a shift from fully virtual to hybrid, hosted at Taichung Veterans General Hospital.
With both online and in-person participation, the experience moved beyond one-way learning to more dynamic, real-time interaction.

We’re grateful for Aplus Biotechnology’s trust, allowing us to deliver an end-to-end approach-from strategy and platform deployment to marketing and on-site execution.
Thank you to the 20+ physicians onsite and nearly 200 online participants who made this exchange truly meaningful.

As healthcare continues to evolve, connecting expertise and amplifying its reach remains at the core of what we do. We look forward to enabling more impactful knowledge exchange in the futu